Page last updated: 2024-09-04

atazanavir sulfate and bms-663068

atazanavir sulfate has been researched along with bms-663068 in 2 studies

Compound Research Comparison

Studies
(atazanavir sulfate)
Trials
(atazanavir sulfate)
Recent Studies (post-2010)
(atazanavir sulfate)
Studies
(bms-663068)
Trials
(bms-663068)
Recent Studies (post-2010) (bms-663068)
1,102246590561356

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertz, R; Furlong, M; Hanna, GJ; Hruska, M; Hwang, C; Landry, IS; Shah, V; Zhu, L1
Hanna, GJ; Joshi, SR; Krystal, M; Lataillade, M; Lee, S; Stock, DA; Zhou, N1

Trials

2 trial(s) available for atazanavir sulfate and bms-663068

ArticleYear
Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Adolescent; Adult; Anti-HIV Agents; Atazanavir Sulfate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Male; Middle Aged; Organophosphates; Piperazines; Ritonavir; Triazoles; Young Adult

2015
Viral Drug Resistance Through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir.
    Journal of acquired immune deficiency syndromes (1999), 2018, 03-01, Volume: 77, Issue:3

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Resistance, Viral; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation, Missense; Organophosphates; Piperazines; Prodrugs; Ritonavir; Sustained Virologic Response; Treatment Outcome; Viral Load

2018